Longevity Research Turns Corner Toward Clinical Drug Breakthroughs
For years, longevity research has been fragmented between understanding *why* we age and testing *whether* individual drugs work—but a major shift is happening right now that's collapsing that gap and pointing the field toward actionable clinical breakthroughs. New research this week reveals the networks that actually drive aging are now mapped, and the field is pivoting from basic science to a practical question that changes everything: which FDA-approved drugs already sitting on pharmacy shelves can we repurpose to hit those targets?
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.